Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.274ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.274ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.274NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.235ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.235ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.235ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.235NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.65ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.65NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.165ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.165ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.165ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.165NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
V.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
V.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
V.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
V.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.149ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.149ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.149NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.413ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.413ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.413ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.413NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.9.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.9.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.107ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.107ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.107ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used